PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsVinorelbine tartrate
Vinorelbine tartrate
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
569 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Breast neoplasmsD001943EFO_0003869C503413951521231
Non-small-cell lung carcinomaD002289217854416169
Lung neoplasmsD008175C34.90195527211107
Triple negative breast neoplasmsD064726119101132
Neoplasm metastasisD009362EFO_00097083136121
Lung diseasesD008171EFO_0003818J98.4112
Thoracic neoplasmsD013899112
Brain stem neoplasmsD020295EFO_100176711
Meningeal carcinomatosisD055756EFO_100101211
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C8025216244
LymphomaD008223C85.98278140
Hodgkin diseaseD006689C814207130
CarcinomaD002277C80.0295218
Non-hodgkin lymphomaD008228C85.949214
Malignant mesotheliomaD000086002293114
Uterine cervical neoplasmsD00258333712
SarcomaD012509561111
RhabdomyosarcomaD01220827311
Adenocarcinoma of lungD0000771925510
Show 28 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Prostatic neoplasmsD011471C614911
MesotheliomaD008654C4529111
Ovarian neoplasmsD010051EFO_0003893C56739
RecurrenceD012008267
Brain neoplasmsD001932EFO_0003833C71177
Small cell lung carcinomaD0557524417
B-cell lymphomaD016393155
Large b-cell lymphoma diffuseD016403C83.355
Ovarian epithelial carcinomaD000077216325
Male breast neoplasmsD018567224
Show 56 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Endometrial neoplasmsD016889EFO_000423022
Adrenocortical carcinomaD01826811
Wilms tumorD009396EFO_000021211
Myeloid leukemia acuteD015470C92.011
Biphenotypic leukemia acuteD015456C95.011
Hematologic neoplasmsD01933711
Peritoneal neoplasmsD01053411
Urinary bladder neoplasmsD001749C6711
Vaginal neoplasmsD014625C5211
Gastrointestinal neoplasmsD005770C26.911
Show 13 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
CarcinogenesisD06364611
MethylationD00874511
Multiple primary neoplasmsD00937811
Progression-free survivalD00007798211
ConstipationD003248K59.011
Desmoid tumorsD018222D48.1111
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
1,869 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use